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Dendritic cells (DCs) interface innate and adaptive immunity
in nonlymphoid organs; however, the exact distribution and
types of DC within the kidney are not known. We utilized
CX3CR1
GFP/þ mice to characterize the anatomy and
phenotype of tissue-resident CX3CR1
þ DCs within normal
kidney. Laser-scanning confocal microscopy revealed an
extensive, contiguous network of stellate-shaped CX3CR1
þ
DCs throughout the interstitial and mesangial spaces of the
entire kidney. Intravital microscopy of the superficial cortex
showed stationary interstitial CX3CR1
þ DCs that continually
probe the surrounding tissue environment through dendrite
extensions. Flow cytometry of renal CX3CR1
þ DCs showed
significant coexpression of CD11c and F4/80, high major
histocompatibility complex class II and FcR expression, and
immature costimulatory but competent phagocytic ability
indicative of tissue-resident, immature DCs ready to respond
to environment cues. Thus, within the renal parenchyma,
there exists little immunological privilege from the
surveillance provided by renal CX3CR1
þ DCs, a major
constituent of the heterogeneous mononuclear phagocyte
system populating normal kidney.
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Dendritic cells (DCs) are sentinels of the immune system,
acting at the crossroads of innate and adaptive immunity,
self-tolerance, and tissue repair and remodeling.1,2 While
DCs are often considered to coordinate these roles after
activation and trafficking into secondary lymphoid organs,3
cumulative evidence suggests that the early integration of
environmental stimuli and signals from adjacent innate
lymphocytes by DCs at nonlymphoid sites of surveillance can
determine whether subsequent immune responses health-
fully resolve local challenges or become injurious.4–6 Within
normal kidney, however, the exact distribution and types
of tissue-resident DCs, and thus, the extent to which DCs
directly survey renal parenchyma and influence localized
immune responses, are unknown. Recent studies7–10 and
earlier observations11–14 have detected DCs in tissue spaces
between tubules, but whether DCs populate glomeruli,15–18
sample the urinary space,19–21 or randomly versus orderly
occupy normal kidney at steady state are not clear.
Here, we investigate the anatomy and phenotype of tissue-
resident DCs within normal kidney using mice in which
a coding exon on one allele of the chemokine receptor,
CX3CR1, has been replaced by an open reading frame
for green fluorescent protein (GFP).22 These heterozygous
‘knock-in’ mice for GFP under the control of the endo-
genous promoter for CX3CR1 (i.e., CX3CR1
GFP/þ ) do not
exhibit any abnormalities and anatomically fate-map by
GFP expression, the distribution and morphology of
tissue-resident CX3CR1
þ DCs that differentiate from bone
marrow-derived, extravasated CX3CR1
þ monocytes.20–27
RESULTS
To address whether any anatomic network of DCs may
exist within normal kidney at steady state, we performed
laser-scanning confocal microscopy across 100 mm thick
coronal kidney sections from CX3CR1
GFP/þ mice. Remark-
ably, stellate-shaped CX3CR1
þ DCs form an extensive,
contiguous network throughout the entire interstitium of
the kidney, extending from the capsule to the papilla (Figures
1 and 2). Dendrite processes from individual CX3CR1
þ DC
terminate near neighboring DC, forming a virtual scaffold
around all nephron units in normal kidney. CX3CR1
þ DCs
encase Bowman’s capsule, and in glomeruli, the presence of
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CX3CR1
þ DCs within extracellular matrix containing
collagen type IV, a component of the mesangium, backs
previous reports showing DCs intermingling with mesangial
cells at low density.15–18 Stellate-shaped CX3CR1
þ DCs also
differentially stain in situ for F4/80, the expression of which is
known to predominate within the medulla (Figure 2d and e
and Figure S1).28 This was confirmed by fluorescence-
activated cell sorter (FACS) on total renal leukocytes which
showed that the majority of renal CX3CR1
þCD11cþ DCs
also express F4/80 (Figure 3 and Table 1), supporting a
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Figure 1 | The contiguous network of CX3CR1
þ DC in the kidney.
(a) Two-dimensional scan of the superficial cortex showing CX3CR1
þ
DCs (GFPþ cells, bright green) abutting the capsule of the kidney
(large arrow) and populating with regular spatial periodicity the
entire interstitial space between tubular segments, discernable owing
to the low level of autofluorescence from tubular cells. CX3CR1
þ DCs
also encase Bowman’s capsules and lie within glomeruli (small
arrows), demarcated from the surrounding tubulointerstitium owing
to the lack of autofluorescence from glomerular cells. (b) Truncated
two-dimensional scan from the capsule (upper left) to the papilla
(lower right) on a section stained with rhodamine-conjugated
peanut agglutinin to highlight distal tubules and collecting ducts.
(c) Magnification of the boxed area in panel b showing CX3CR1
þ
DCs populating the interstitium of the medulla, including its
transition into pyramidal tracks. Note the same spatial regularity as in
the cortex. (d) A representative three-dimensional rendering of
tubular segments in the medulla (recolored to highlight GFP signals)
showing stellate-shaped CX3CR1
þ DCs surrounding all tubules, with
dendrite extensions from one DC terminating near adjacent DC.
Images shown are representative of six independent experiments
performed on six CX3CR1
GFP/þ mice.
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Figure 2 | Phenotypic heterogeneity of renal CX3CR1
þ DC.
(a) Three-dimensional rendering of a section through a glomerulus
showing intraglomerular CX3CR1
þ DCs (arrows) circumscribed by
CX3CR1
þ DCs encasing Bowman’s capsule. As exemplified in this
panel, the morphology of intraglomerular CX3CR1
þ DCs are
consistently less stellate-appearing than CX3CR1
þ DCs located in
either the tubulointerstitium or around Bowman’s capsule. Inset
is a black-and-white image of this panel showing the degree of
rotation and circumference of Bowman’s capsule (large dashed line).
(b) Two-dimensional, 5 mm thin section of a glomerulus showing both
extraglomerular (small arrows) and intraglomerular (large arrow)
CX3CR1
þ DCs soma. (c) Simultaneous immunofluorescence from
rhodamine-labeled collagen type IV and CX3CR1
þ DCs of panel b
suggests that intraglomerular CX3CR1
þ DCs lie within, not outside,
the mesangium. (d) Two-dimensional scan of juxta-medullary
tubulointerstitium stained with Alexa-647-conjugated anti-F4/80
antibody. Several stellate-shaped orange-yellow cells (a fluorescent
signal caused by the merge of Alexa-647-conjugated anti-F4/80
antibody staining of GFPþ cells) lying within the interstitium are
adjacent to stellate-shaped CX3CR1
þ DCs that do not stain for F4/80.
(e) Magnification of the boxed area in panel d highlights the
differential expression of F4/80 by renal CX3CR1
þ DCs. Images
shown are representative of six independent experiments
performed on six CX3CR1
GFP/þ mice.
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Figure 3 | Flow cytometry of renal CX3CR1
þ DCs. All results are listed in Table 1. (a) Representative FACS contour plot of the expression of
CX3CR1 (GFP
þ ) and CD11c, a conventional DC marker, on total tissue-resident renal leukocytes reveals three distinct populations (boxed)
consisting of CX3CR1
-CD11cþ (15%), CX3CR1
þ -CD11cþ (16.5%), and CX3CR1
þ -CD11c cells (7%). (b) Representative FACS histograms for the
expression of DC maturation markers (MHC II, CD80), conventional macrophage markers (CD11b, F4/80), and immunoglobulin receptors (FcgR
II/III) by the three separate populations in panel a. The isotype staining controls are the dotted histograms in the left panels. (c) Representative
FACS histogram (left panel) for MHC II expression on total tissue-resident renal leukocytes 20 h after administration of 2 MDa dextran. Contour
plots of the MHC II pool (middle panel) and MHC IIþ pool (right panel) of these total tissue-resident renal leukocytes were analyzed for
CX3CR1 expression and uptake of 2 MDa dextran. (d) Pie graphs depicting the heterogeneity of CD11c and F4/80 on tissue-resident
CX3CR1
þCD11bþ renal leukocytes versus tissue-resident CX3CR1
CD11bþ renal leukocytes. Only 3% of the CX3CR1
þCD11bþ population do
not express either CD11c or F4/80 as compared to 37% of the CX3CR1
CD11bþ population, suggesting that CX3CR1 tightly marks interstitial
DC lineage(s), the majority of which express both CD11c and F4/80. The CX3CR1
CD11bþ population likely represents a heterogeneous
mixture of additional DCs subtypes (please see Table 1), macrophages subtypes, and other innate immune cells. Results shown are
representative data obtained from four independent experiments using three mice per experiment.
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similar finding by Kruger et al.7 Unlike in the gastrointestinal
tract of CX3CR1
GFP/þ mice,20,21 transepithelial extensions of
CX3CR1
þ DC dendrites into the urinary space were not
readily visualized in either glomerular or tubular portions of
normal nephrons. This suggests that any sampling of the
‘sterile’ urinary space by DCs, if it occurs, is infrequent
under physiologic conditions or, alternatively, is not easily
detected by our microscopy on fixed tissue, requiring
more sensitive techniques. Nonetheless, intravital micro-
scopy of the superficial cortex showed constant probing
and sampling of the environment by dendrites emanating
from stationary CX3CR1
þ DCs soma within the interstitium,
cellular dynamics readily distinguished from the intravascular
trafficking of CX3CR1
þ blood monocytes (movies in Figure
S2 and Figure S3).
Profiling by flow cytometry (Figure 3 and Table 1)
suggests that the vast majority of renal CX3CR1
þ DCs are
similar to the ‘interstitial’ DCs subtype described in other
nonlymphoid organs such as the lung.29 Renal CX3CR1
þ
CD11cþCD11bþ and CX3CR1
þCD11cCD11bþ DC
populations are largely negative for CD8a and B220
expression (i.e., markers of lymphoid and plasmacytoid
DCs, respectively) and, as expected for tissue-resident DCs at
steady state,1–6 display an immature costimulatory capacity
(i.e., high major histocompatibility complex (MHC) class II
expression but low CD80, CD86, and CD40 expression).
Despite this immaturity, renal CX3CR1
þ DCs demonstrate
a clear ability to acquire foreign antigen. Intravenously
injected 2 MDa dextran is macropinocytosed by renal
CX3CR1
þ DCs at levels 5–15 fold-greater than analogous
splenocyte populations (Figure 3 and Table 1). Renal
CX3CR1
þ DCs are also competent to bind immunoglobulins
as they express significant levels of FcgR II/III immuno-
globulin receptors (Figure 3 and Table 1). Taken together,
these results suggest that renal CX3CR1
þ DCs exist in an
immature state, competent to acquire antigen and ready to
respond to external stimuli.
DISCUSSION
Tissue-resident DCs of the mononuclear phagocyte system
constitute an increasingly heterogeneous population of cells;
however, one shared feature across this lineage is its anatomic
readiness to respond to insults to the parenchyma it
surveys.1–6 Although DCs have been detected in various
renal compartments by several techniques,7–18 we describe
here for the first time, through confocal imaging of renal
parenchyma from the capsule to the papilla and by intravital
microscopy of superficial renal cortex in live CX3CR1
GFP/þ
mice, a pervasive network of stellate-shaped interstitial
CX3CR1
þ DCs within normal kidney. Thus, interstitial
CX3CR1
þ DCs are positioned to serve as a major interface
between innate and adaptive immunity throughout the entire
kidney. As a minority of CX3CR1
þ renal leukocytes did
not express the canonical DC marker, CD11c, but did express
the canonical macrophage marker, F4/80, we cannot formally
exclude the possibility that the network of immature renal
CX3CR1
þ DCs does not also include a more macrophage-
like lineage or a differentiating, CD11c DC precursor. Yet,
to date, microglia in the brain have been the only macro-
phage or macrophage-like lineage found to express CX3CR1
within the nonlymphoid tissues of CX3CR1
GFP/þ mice at
normal steady state.20–26 Our results more closely parallel the
observations of other recent studies that identify hetero-
geneous expression of conventional macrophage markers
(e.g., F4/80 and CD11b) on tissue-resident DCs sub-
types.21,29–33 Indeed, this study underscores the rapid,
ongoing evolution of our understanding and manipulation
of the mononuclear phagocyte system in many nonlymphoid
tissues. For example, diphtheria toxin receptor-mediated
ablation of CD11bþ macrophages within kidneys of CD11b-
diphtheria toxin receptor mice34 would presumably eliminate
most renal CX3CR1
þ DCs as well, analogous to how
previously unrecognized splenic CD11cþ macrophage sub-
types are eliminated during ablation of CD11cþ DCs in
CD11c-diphtheria toxin receptor mice.35 Similarly, clodro-
nate liposome-mediated ablation of renal phagocytic cells is
thought to specifically target monocytes and macrophages;
however, our observations suggest that clodronate liposome
treatment would also eliminate the majority of renal DCs and
thus, remove the bulk of the mononuclear phagocyte system
in the kidney.36,37 In any regard, this study provides a
foundation on which to further explore the complexity of the
mononuclear phagocyte system within normal kidney and
how renal CX3CR1
þ DCs may play a role in the pathogenesis
and treatment of specific renal diseases.
MATERIALS AND METHODS
Mice
All studies using 8–12-week-old CX3CR1
GFP/þ mice, genotyped as
previously described,22 complied with IACUC regulations of the
Table 1 | FACS characterization of renal CX3CR1
+ DC com-
pared to analogous splenocytes
CX3CR1
+ CD11c+ CX3CR1
+ CD11c CX3CR1
 CD11c+
Markera Kidney Spleen Kidney Spleen Kidney Spleen
CD11b + + + + + +
MHC II + + + (75%)  (o10%) + (75%) +
F4/80 Low (66%) Low Low (75%) Low Low (50%) Low
CD4  (o5%) + (35%)   + (30%) + (55%)
CD8a  (o5%) + (20%)   + (10%) + (13%)
B220      
NK1.1   (6%)   (7%)  
CD3e      
GR-1      +
CD80 Low Low Low Low Low Low
CD86 Low Low Low Low Low Low
CD40      
FcgR II/III + + (65%) + + + (50%) + (80%)
2 MDa dextran + (39%)  (7%) + (52%)  (3%) + (15%)  (3%)
DC, dendritic cell; FACS, fluorescence-activated cell sorter; MHC, major histocompat-
ibility complex.
aUnless the percentage is indicated, a marker is considered to be ‘+’ if it is expressed
on greater than 90% of cells, ‘’ if it is expressed on less than 10% of cells, and ‘low’
when compared to activated cells or to conventionally high expressing cell-types.
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New York University School of Medicine. Aside from the
preparation of mice for intravital microscopy (described below),
mice were anesthetized, perfusion-flushed with 40 ml 1 phosphate-
buffered saline (pH 7.4, 371C), or perfusion-flushed followed
immediately by perfusion-fixation with 20 ml of 4% paraformalde-
hyde (pH 7.4, room temperature), before excision of kidneys for
flow cytometry or microscopy studies, respectively.
Microscopy
A 100-mm-thick coronal sections were prepared using a vibratome
and imaged by laser-scanning confocal microscopy (Zeiss,
Oberkochen, Germany, LSM 510 single photon inverted micro-
scope) from the capsule to the papilla. Two- and three-dimensional
image reconstruction and analysis were performed using the
Volocity (Improvision Ltd., Coventry, England) and Metamorph
(Molecular Devises, Downingtown, PA, USA) software. The buffer
for staining or washing of sections was 1 phosphate-buffered
saline (pH 7.4) containing 2% bovine serum albumin and 1%
Triton X-100. Some sections were incubated with 5 mg rhodamine-
conjugated peanut agglutinin (Vector Laboratories, Burlingame, CA,
USA) in 200 ml buffer for 12–20 h to stain distal tubules and
collecting ducts before imaging. Tissue-resident F4/80þ cells were
detected by staining sections with 0.2 mg Alexa-647-conjugated
anti-F4/80 antibody (Caltag, Burlingame, CA, USA, clone BM-8) in
200ml of buffer for 12 h after blocking Fc receptors with 5 mg
anti-CD16/32 antibody (Pharmigen, San Jose, CA, USA, clone
2.4G2). Localization of CX3CR1
þ DCs within the glomerulus by
immunofluorescence was performed on 5-mm-thick frozen sections
from bisected kidneys incubated in 30% sucrose overnight at 41C
and embedded in 22-oxacalcitriol. Sections were stained with rabbit
antimouse collagen type IV antibody (Chemicon International,
Temecula, CA, USA, 1:80) followed by rhodamine-conjugated swine
antirabbit antibody (DakoCytomation, Glostrup, Denmark, 1:20).
Collagen type IV was chosen because it is a major extracellular
matrix component of tubular and glomerular basement membranes,
Bowman’s capsule, and the mesangium.
Intravital microscopy was performed on live CX3CR1
GFP/þ mice
as described before.38 Briefly, one kidney was exposed in
anesthetized mice through an incision along the flank of the body,
immobilized, then imaged within the superficial renal cortex using
the Zeiss LSM 510 microscope. Mice received oxygen, periodic
boosts of anesthesia every 30 min, and an injection of phosphate-
buffered saline intravenously every 45 min. Images were taken every
30 s for 20 min and collated together to generate a movie using the
Velocity software.
Flow cytometry
Kidneys were digested with 2 mg/ml collagenase B (Sigma, St. Louis,
MO, USA) and 0.2 mg/ml. DNAse I (Sigma) in Hank’s balanced salt
solution (Gibco, Carlsbad, CA, USA) supplemented with 1% bovine
serum albumin, 25 mM NaHCO3 and 10 mM N-2-hydroxyethylpi-
perazine-N0-2-ethanesulfonic acid for 30 min at 371C with gentle
agitation. Leukocytes from digested kidneys were isolated over a
40–80% Percoll (Amersham, Uppsala, Sweden) gradient, washed,
blocked with 5 mg of anti-CD16/32 antibody (Pharmigen; clone
2.4G2) (except for detection of FcgR II/III), and stained with
antibodies diluted 1:200 in 1 phosphate-buffered saline (pH 7.4)
containing 1% bovine serum albumin and 0.01% Na-azide.
Antibodies to phenotypic and functional markers on DCs included:
from Pharmigen – CD11c (clone HL3), CD11b (clone M1/70), I-Ab
(MHC II, clone AF6-120.1), CD16/32 (clone 2.4G2), LY6G/6C
(GR-1, clone RB6-8C5), CD80 (B7-1, clone 16-10A1), CD86 (B7-2,
clone GL-1), CD40 (clone 3/23), CD4 (clone SK3), CD8a (clone
53–6.7), CD45R (B220, clone RA3-6B2), CD3e (clone 145-2C11),
and NK1.1 (clone PK136); from Caltag – F4/80 (clone BM-8). To
detect macropinocytosis by CX3CR1
þ DCs within the kidney, mice
were injected with 50 mg Alexa 647-conjugated 2 MDa dextran
(Molecular Probes, Carlsbad, CA, USA) 20 h before kidney leukocyte
isolation as described above. FACS acquisition was performed using
an LSR II flow cytometer (Becton Dickinson, Franklin Lakes, NJ,
USA) and analysis performed using FloJo (Treestar, Stanford
University, Ashland, OR, USA) software. FACS controls were
splenocytes, prepared as previously described,22 from the same mice
analyzed in tandem with renal leukocytes.
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SUPPLEMENTARY MATERIAL
Figure S1. F4/80þ cells are concentrated in the renal medulla of
CX3CR1
GFP/þ mice.
Figure S2. Intravital microscopy of live CX3CR1
þ DC in the superficial
renal cortex.
Figure S3. Intravital microscopy of live CX3CR1
þ DC dendrite
sampling in the superficial renal cortex.
REFERENCES
1. Granucci F, Foti M, Ricciardi-Castagnoli P. Dendritic cell biology.
Adv Immunol 2005; 88: 193–233.
2. Adams S, O’Neill DW, Bhardwaj N. Recent advances in dendritic cell
biology. J Clin Immunol 2005; 25: 177–188.
3. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine
Growth Factor Rev 2005; 16: 581–592.
4. Tan JK, O’Neill HC. Maturation requirements for dendritic cells in T cell
stimulation leading to tolerance versus immunity. J Leukoc Biol 2005; 78:
319–324.
5. Munz C, Steinman RM, Fujii S. Dendritic cell maturation by innate
lymphocytes: coordinated stimulation of innate and adaptive immunity.
J Exp Med 2005; 202: 203–207.
6. Mazzoni A, Segal DM. Controlling the Toll road to dendritic cell
polarization. J Leukoc Biol 2004; 75: 721–730.
7. Kruger T, Benke D, Eitner F et al. Identification and functional
characterization of dendritic cells in the healthy murine kidney and in
experimental glomerulonephritis. J Am Soc Nephrol 2004; 15: 613–621.
8. Dong X, Swaminathan S, Bachman LA et al. Antigen presentation by
dendritic cells in renal lymph nodes is linked to systemic and local injury
to the kidney. Kidney Int 2005; 68: 1096–1108.
9. Coates PT, Colvin BL, Ranganathan A et al. CCR and CC chemokine
expression in relation to Flt3 ligand-induced renal dendritic cell
mobilization. Kidney Int 2004; 66: 1907–1917.
10. Coates PT, Duncan FJ, Colvin BL et al. In vivo-mobilized kidney dendritic
cells are functionally immature, subvert alloreactive T-cell responses, and
prolong organ allograft survival. Transplantation 2004; 77: 1080–1089.
11. Lemley KV, Kriz W. Anatomy of the renal interstitium. Kidney Int 1991; 39:
370–381.
12. Kaissling B, Le Hir M. Characterization and distribution of interstitial cell
types in the renal cortex of rats. Kidney Int 1994; 45: 709–720.
13. Austyn JM, Hankins DF, Larsen CP et al. Isolation and characterization of
dendritic cells from mouse heart and kidney. J Immunol 1994; 152:
2401–2410.
14. Kaissling B, Hegyi I, Loffing J et al. Morphology of interstitial cells in the
healthy kidney. Anat Embryol 1996; 93: 303–318.
15. Schreiner GF, Kiely JM, Cotran RS et al. Characterization of resident
glomerular cells in the rat expressing Ia determinants and manifesting
genetically restricted interactions with lymphocytes. J Clin Invest 1981;
68: 920–931.
Kidney International (2006) 70, 591–596 595
TJ Soos et al.: Dendritic network in the kidney r a p i d c o m m u n i c a t i o n
16. Schreiner GF, Cotran RS. Localization of an Ia-bearing glomerular cell in
the mesangium. J Cell Biol 1982; 94: 483–488.
17. Schreiner GF, Unanue ER. Origin of the rat mesangial phagocyte and its
expression of the leukocyte common antigen. Lab Invest 1984; 51:
515–523.
18. Gieseler R, Hoffmann PR, Kuhn R et al. Enrichment and characterization of
dendritic cells from rat renal mesangium. Scand J Immunol 1997; 46:
587–596.
19. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight
junction proteins and penetrate gut epithelial monolayers to sample
bacteria. Nat Immunol 2001; 2: 361–367.
20. Niess JH, Brand S, Gu X et al. CX3CR1-mediated dendritic cell access
to the intestinal lumen and bacterial clearance. Science 2005; 307:
254–258.
21. Vallon-Eberhard A, Landsman L, Yogev N et al. Transepithelial pathogen
uptake into the small intestine lamina propia. J Immunol 2006; 176:
2465–2469.
22. Jung S, Aliberti J, Graemmel P et al. Analysis of fractalkine receptor
CX3CR1 function by targeted deletion and green fluorescent protein
reporter gene insertion. Mol Cell Biol 2000; 20: 4106–4114.
23. Geissman F, Jung S, Littman DR. Blood monocytes consist of two
principle subsets with distinct migratory properties. Immunity 2003; 19:
71–82.
24. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are
highly dynamic surveillants of brain parenchyma in vivo. Science 2005;
308: 1314–1318.
25. Davalos D, Grutzendler J, Yang G et al. ATP mediates rapid microglial
response to local brain injury in vivo. Nat Neurosci 2005; 8: 752–758.
26. Srivastava M, Jung S, Wilhelm J et al. The inflammatory versus
constitutive trafficking of mononuclear phagocytes into the alveolar
space of mice is associated with drastic changes in their gene expression
profiles. J Immunol 2005; 175: 1884–1893.
27. Fogg DK, Sibon C, Miled C et al. A clonogenic bone marrow progenitor
specific for macrophages and dendritic cells. Science 2006; 311: 83–87.
28. Hume DA, Gordon S. Mononuclear phagocyte system of the mouse
defined by immuno-histochemical localization of antigen F4/80.
Identification of resident macrophages in renal medullary and cortical
interstitium and the juxtaglomerular complex. J Exp Med 1983; 157:
1704–1709.
29. Jan de Heer H, Hammad H, Kool M et al. Dendritic cell subsets and
immune regulation in the lung. Semin Immunol 2005; 17: 295–303.
30. Padilla J, Daley E, Chow A et al. IL-13 regulates the immune response to
inhaled antigens. J Immunol 2005; 174: 8097–8105.
31. Sasmono RT, Oceandy D, Pollard JW et al. A macrophage colony-
stimulating factor receptor-green fluorescent protein transgene is
expressed throughout the mononuclear phagocyte system of the mouse.
Blood 2003; 101: 1155–1163.
32. Pillarisetty VG, Shah AB, Miller G et al. Liver dendritic cells are less
immunogenic than spleen dendritic cells because of differences in
subtype composition. J Immunol 2004; 172: 1009–1017.
33. Garnier CV, Filgueira L, Wikstrom M et al. Anatomic location determines
the distribution and function of dendritic cells and other APCs in the
respiratory tract. J Immunol 2005; 175: 1609–1618.
34. Duffield JS, Tipping PG, Kipari T et al. Conditional ablation of
macrophages halts progression of crescentic glomerulonephritis. Am J
Pathol 2005; 167: 1207–1219.
35. Probst HC, Tschannen K, Odermatt B et al. Histologic analysis of
CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp
Immunol 2005; 141: 398–404.
36. D’Souza MJ, Oettinger CW, Shah A et al. Macrophage depletion by
albumin microencapsulated clodronate: attenuation of cytokine release
in macrophage-dependent glomerulonephritis. Drug Dev Ind Pharm 1999;
5: 591–596.
37. Van Rooijen N. The liposome-mediated macrophage ‘suicide’ technique.
J Immunol Methods 1989; 124: 1–6.
38. Geissmann F, Cameron TO, Sidobre S et al. Intravascular immune
surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLOS Biol
2005; 3: 650–661.
596 Kidney International (2006) 70, 591–596
r a p i d c o m m u n i c a t i o n TJ Soos et al.: Dendritic network in the kidney
